Sinew Pharma Inc Sustainability Reports
Sinew Pharma Inc. is a biotech company focused on researching and developing therapeutic products for liver and pain treatments. It specializes in treatments for metabolic dysfunction-associated steatohepatitis (MASH) and acetaminophen-induced liver injury.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG00H09BNB7
1 reports from 2022 to 2022
Company Profile
Sinew Pharma Inc. is a biotech company focused on researching and developing therapeutic products for liver and pain treatments. It specializes in treatments for metabolic dysfunction-associated steatohepatitis (MASH) and acetaminophen-induced liver injury.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years